The randomized, placebo-controlled trial demonstrated that curcumin supplementation significantly improved indicators of anti-atherogenic activity in patients with Type 2 diabetes and obesity over a 12-month period.
This study highlights curcumin's potential not only as an antioxidant and anti-inflammatory agent but also in improving heart health, particularly in at-risk populations.
Collection
[
|
...
]